RBS/CityU of HK receives prestigious RIF grant to study cancer treatment

RBS together in collaborative sponsorship with City Universtiy of Hong Kong and Prof. Chen Chia Hung's lab, has received the competitive HK Research Impact Fund (RIF) grant of 5M HKD to study functional dynamics of cancer cells using RBS' and CityU's proprietary platfrom microfluidic sorting technology.

Next
Next

Rain Biotech Solutions to Exhibit at the 2024 BEYOND Expo in Macao